or
forgot password

    • cancer clinical trials in normal, IL

    • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Breast Cancer
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Lymphoma
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Illinois CancerCare - Community Cancer Center
    Normal, Illinois 61761
    Lung Cancer
    Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Adult Acute Lymphoblastic Leukemia in Remission
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Breast Cancer
    Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
    Mid-Illinois Hematology and Oncology Associates, Ltd.
    Normal, Illinois 61761
    Breast Cancer
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Leukemia
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Illinois CancerCare-Community Cancer Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Recurrent Mantle Cell Lymphoma
    Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Illinois CancerCare-Community Cancer Center
    Normal, Illinois 61761
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Chronic Myeloproliferative Disorders